MeSH term
Frequency | Condition_Probility | Female | 7 | 0.0 |
Humans | 38 | 0.0 |
Pregnancy | 2 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Male | 34 | 0.0 |
Middle Aged | 7 | 0.0 |
Racemases and Epimerases/*analysis | 6 | 100.0 |
Sensitivity and Specificity | 9 | 0.0 |
Tumor Markers, Biological/*analysis | 7 | 0.0 |
Blotting, Western | 2 | 0.0 |
Immunohistochemistry | 17 | 0.0 |
*Membrane Proteins | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Prostatectomy | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Biopsy, Needle | 4 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Tumor Markers, Biological/genetics/*metabolism | 2 | 5.0 |
Prospective Studies | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Racemases and Epimerases/*metabolism | 7 | 87.0 |
Adult | 4 | 0.0 |
Racemases and Epimerases/*biosynthesis | 3 | 100.0 |
Prostate-Specific Antigen/blood | 2 | 2.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Prostatic Neoplasms/*enzymology/pathology/surgery | 2 | 100.0 |
Tumor Markers, Biological/metabolism | 3 | 0.0 |
Comparative Study | 6 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Mice | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Racemases and Epimerases/*immunology | 2 | 100.0 |
Case-Control Studies | 3 | 0.0 |
Diagnosis, Differential | 4 | 0.0 |
Prostatic Neoplasms/*diagnosis/*enzymology | 2 | 100.0 |
*Biopsy, Needle | 4 | 11.0 |
Prostate/*pathology | 2 | 8.0 |
Staining and Labeling | 2 | 0.0 |
Prostatic Neoplasms/*enzymology/pathology | 2 | 18.0 |
Tumor Markers, Biological | 3 | 0.0 |
Prostatic Neoplasms/enzymology/*genetics/pathology | 2 | 28.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Adenoma/enzymology | 2 | 28.0 |
Racemases and Epimerases/genetics/*metabolism | 2 | 100.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Racemases and Epimerases/*genetics | 2 | 100.0 |
